Related Experiment Video
Updated: Jun 19, 2026

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
Published on: September 2, 2020
The vanilloid receptor TRPV1: role in cardiovascular and gastrointestinal protection
1Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha 410078, China.
Abstract:
It has been shown that the transient receptor potential channel vanilloid type 1 (TRPV1) is able to sense a vast range of stimuli and exerts multiple functions under physiological or pathophysiological conditions. TRPV1 not only plays a fundamental role in pain signaling but also involves in many other physiological or pathophysiological functions including the beneficial effects on cardiovascular and gastrointestinal function. It has been found that TRPV1 could be activated by endogenous ligands such as anandamide, N-arachidonoyl dopamine and N-oleoyldopamine or by exogenous agonists such as capsaicin and rutaecarpine. Since capsaicin-sensitive sensory nerves (rich in TRPV1) are densely distributed in the cardiovascular and gastrointestinal system, activation of TRPV1 either by endogenous ligands or by exogenous agonists has been repeatedly reported to exert hypotensive effects or protective effects against cardiac or gastrointestinal injury through stimulating the synthesis and release of multiple neurotransmitters such as calcitonin gene-related peptide and substance P. Therefore, TRPV1 is not only a prime target for the pharmacological control of pain but also a useful target for drug development to treat various diseases including cardiovascular and gastrointestinal diseases. However, considering the contribution of TRPV1 to the development of inflammation in the gastrointestinal tract, the potential side effects of TRPV1 agonist cannot be neglected while in seeking and developing the novel TRPV1 agonists.
Insights
The transient receptor potential channel vanilloid type 1 (TRPV1) plays a key role in pain and cardiovascular/gastrointestinal functions. TRPV1 activation offers therapeutic potential for various diseases, but potential side effects require careful consideration.
Area of Science:
- Pharmacology
- Physiology
- Neuroscience
Background:
- Transient receptor potential channel vanilloid type 1 (TRPV1) senses diverse stimuli and has roles in physiological and pathophysiological processes.
- TRPV1 is crucial in pain signaling and influences cardiovascular and gastrointestinal functions.
- TRPV1 can be activated by endogenous ligands (e.g., anandamide) and exogenous agonists (e.g., capsaicin).
Purpose of the Study:
- To explore the multifaceted roles of TRPV1 beyond pain signaling.
- To investigate TRPV1's involvement in cardiovascular and gastrointestinal physiology and pathophysiology.
- To assess TRPV1 as a therapeutic target for cardiovascular and gastrointestinal diseases.
Main Methods:
- Review of existing literature on TRPV1 activation and its downstream effects.
- Analysis of studies investigating TRPV1's role in cardiovascular and gastrointestinal systems.
- Examination of neurotransmitter release (e.g., CGRP, substance P) following TRPV1 activation.
Main Results:
- TRPV1 activation by endogenous or exogenous compounds can lead to hypotensive effects.
- TRPV1 activation demonstrates protective effects against cardiac and gastrointestinal injury.
- Stimulation of neurotransmitter synthesis and release (CGRP, substance P) is a key mechanism.
Conclusions:
- TRPV1 is a significant target for pain management and drug development for cardiovascular and gastrointestinal diseases.
- TRPV1 activation may offer therapeutic benefits for conditions like hypertension and organ injury.
- Potential side effects, including gastrointestinal inflammation, must be addressed in novel TRPV1 agonist development.
Related Concept Videos
Thermosensation
Mechanically-gated Ion Channels
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Enteric Nervous System: Regulation of GI Motor Activity
During periods of fasting, the ENS initiates the migrating myoelectric complex, a program...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Physiology of Enteric Nervous System and Gut Health
